Nîmes, a city in the Occitanie region of southern France, was an important outpost of the Roman Empire. It’s known for well-preserved Roman monuments such as the Arena of Nîmes, a double-tiered circa-70 A.D. amphitheater still in use for concerts and bullfights. Both the Pont du Gard tri-level aqueduct and the Maison Carrée white limestone Roman temple are around 2,000 years old. ― Google

During the past decade, Nîmes cedex conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nîmes cedex" are "Parkinson Disease" (2 trials). Many other conditions were trialed in "Nîmes cedex" in a lesser frequency.

Most popular intervention types in "Nîmes cedex" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "Tavapadon" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nîmes cedex" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nîmes cedex". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Nîmes cedex, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nîmes cedex, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".